BBI 4007

Drug Profile

BBI 4007

Latest Information Update: 16 Apr 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer Nonindustrial source
  • Class Antiulcers; Bifidobacteria
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Gastric ulcer

Most Recent Events

  • 16 Apr 1997 No-Development-Reported for Gastric ulcer in Japan (Unknown route)
  • 23 Jan 1995 New profile
  • 23 Jan 1995 Investigation in Gastric ulcer in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top